| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.31 | 0.1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |